Drug trade group sues Maryland over first-in-the-nation price-gouging law

Washington Post

6 July 2017 - A generic-drug trade group is suing Maryland over a price-gouging law that is set to go into effect in October.

In a federal lawsuit filed Thursday against state Attorney General Brian E. Frosh and Dennis Schrader, the secretary of the state Department of Health, the Association for Accessible Medicines asked the U.S. District Court of Maryland in Greenbelt for an injunction to block the law, which it argues is unconstitutional.

“It will harm patients and our communities by reducing choice and limiting access to essential medicines that people need,” Chip Davis, chief executive officer of the association, said in a statement.

Read Washington Post article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing , Gene therapy , Maryland